Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Science Translational Medicine
|
November 9, 2022
BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion
In-Young Jung, Vivek Narayan, Sierra McDonald, et al.
Cancer Discovery
|
April 3, 2023
Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T Cell-Intrinsic Dysfunction
In-Young Jung, Robert L Bartoszek, Andrew J Rech, et al.
Nature
|
March 11, 2015
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor, Andrew J Rech, Amit Maity, et al.
Immunity
|
July 1, 2018
Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy
Jinyang Li, Katelyn T Byrne, Fangxue Yan, et al.
Cell Reports. Medicine
|
August 19, 2025
Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer
M Angela Aznar, Charly R Good, Julie S Barber-Rotenberg, et al.
Nature Medicine
|
June 1, 2025
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial
Stephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
Nature Medicine
|
June 11, 2025
Author Correction: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial
Stephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
Nature Biomedical Engineering
|
March 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer
Gregory M Chen, Ankita Jain, David T Gering, et al.
Cell
|
October 10, 2020
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Daniel K Wells, Marit M van Buuren, Kristen K Dang, et al.
Nature Medicine
|
March 22, 2022
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Vivek Narayan, Julie S Barber-Rotenberg, In-Young Jung, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Science Translational Medicine
|
November 9, 2022
BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion
In-Young Jung, Vivek Narayan, Sierra McDonald, et al.
Cancer Discovery
|
April 3, 2023
Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T Cell-Intrinsic Dysfunction
In-Young Jung, Robert L Bartoszek, Andrew J Rech, et al.
Nature
|
March 11, 2015
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor, Andrew J Rech, Amit Maity, et al.
Immunity
|
July 1, 2018
Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy
Jinyang Li, Katelyn T Byrne, Fangxue Yan, et al.
Cell Reports. Medicine
|
August 19, 2025
Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer
M Angela Aznar, Charly R Good, Julie S Barber-Rotenberg, et al.
Nature Medicine
|
June 1, 2025
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial
Stephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
Nature Medicine
|
June 11, 2025
Author Correction: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial
Stephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
Nature Biomedical Engineering
|
March 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer
Gregory M Chen, Ankita Jain, David T Gering, et al.
Cell
|
October 10, 2020
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Daniel K Wells, Marit M van Buuren, Kristen K Dang, et al.
Nature Medicine
|
March 22, 2022
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Vivek Narayan, Julie S Barber-Rotenberg, In-Young Jung, et al.
Page
of 3